Literature DB >> 19346104

Development of a hyaluronan bioconjugate for the topical treatment of melanoma.

Li-Shu Zhang, Henry J Greyner, Mark E Mummert, W Matthew Petroll.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19346104      PMCID： PMC2693084          DOI： 10.1016/j.jdermsci.2009.02.014

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN： 0923-1811            Impact factor:   4.563


× No keyword cloud information.
  5 in total

1.  Absorption of hyaluronan applied to the surface of intact skin.

Authors:  T J Brown; D Alcorn; J R Fraser
Journal:  J Invest Dermatol       Date:  1999-11       Impact factor: 8.551

2.  Reduced level of CD44 and hyaluronan associated with unfavorable prognosis in clinical stage I cutaneous melanoma.

Authors:  J M Karjalainen; R H Tammi; M I Tammi; M J Eskelinen; U M Agren; J J Parkkinen; E M Alhava; V M Kosma
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

3.  An in vitro investigation into the effect of glycosaminoglycans on the skin partitioning and deposition of NSAIDs.

Authors:  M B Brown; M Hanpanitcharoen; G P Martin
Journal:  Int J Pharm       Date:  2001-08-28       Impact factor: 5.875

4.  Cellular membrane permeability of anthracyclines does not correlate with their delivery in a tissue-isolated tumor.

Authors:  M Heijn; S Roberge; R K Jain
Journal:  Cancer Res       Date:  1999-09-01       Impact factor: 12.701

5.  Development of a peptide inhibitor of hyaluronan-mediated leukocyte trafficking.

Authors:  M E Mummert; M Mohamadzadeh; D I Mummert; N Mizumoto; A Takashima
Journal:  J Exp Med       Date:  2000-09-18       Impact factor: 14.307
  5 in total
  4 in total

1.  A RHAMM mimetic peptide blocks hyaluronan signaling and reduces inflammation and fibrogenesis in excisional skin wounds.

Authors:  Cornelia Tolg; Sara R Hamilton; Ewa Zalinska; Lori McCulloch; Ripal Amin; Natalia Akentieva; Francoise Winnik; Rashmin Savani; Darius J Bagli; Len G Luyt; Mary K Cowman; Jim B McCarthy; Eva A Turley
Journal:  Am J Pathol       Date:  2012-08-11       Impact factor: 4.307

2.  A stimulatory TSH receptor antibody enhances adipogenesis via phosphoinositide 3-kinase activation in orbital preadipocytes from patients with Graves' ophthalmopathy.

Authors:  Seema Kumar; Sarah Nadeem; Marius N Stan; Michael Coenen; Rebecca S Bahn
Journal:  J Mol Endocrinol       Date:  2011-04-12       Impact factor: 5.098

Review 3.  Interactions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and Cancer.

Authors:  Suniti Misra; Vincent C Hascall; Roger R Markwald; Shibnath Ghatak
Journal:  Front Immunol       Date:  2015-05-06       Impact factor: 7.561

4.  Lipid-Based Nanovectors for Targeting of CD44-Overexpressing Tumor Cells.

Authors:  Silvia Arpicco; Giuseppe De Rosa; Elias Fattal
Journal:  J Drug Deliv       Date:  2013-03-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.